[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![REDBOXINDIA Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1092883822473924608.png) RedboxGlobal India [@REDBOXINDIA](/creator/twitter/REDBOXINDIA) on x 367.1K followers
Created: 2025-07-10 11:57:52 UTC

Glenmark : Subsidiary IGI has signed a $XXX million global licensing deal with AbbVie for its oncology asset ISB 2001.

The agreement includes $XXXXX billion in potential milestones and tiered double-digit royalties.

ISB 2001 is a first-in-class trispecific antibody for relapsed/refractory multiple myeloma, with a XX% response rate in early trials.

AbbVie will handle development and commercialization across major global markets.

The deal validates IGI’s BEAT®️ platform and marks a major value unlock, boosting Glenmark’s long-term growth and innovation focus


XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1943278495498670552/c:line.svg)

**Related Topics**
[india](/topic/india)
[$abbv](/topic/$abbv)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/REDBOXINDIA/status/1943278495498670552)